A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: lessons learned and evolving practices.

Africa Clinical presentation Mpox Prevention measures Risk factors

Journal

IJID regions
ISSN: 2772-7076
Titre abrégé: IJID Reg
Pays: England
ID NLM: 9918418183106676

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 16 04 2024
revised: 30 06 2024
accepted: 02 07 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

In recent years, mpox, a zoonotic disease caused by the mpox virus, has transcended its primary association with Central and West Africa, emerging as a global public health concern. The virus poses a substantial threat, particularly, to vulnerable demographics such as young children and individuals with compromised immune systems. This critical literature review aimed to comprehensively evaluate the burden, risk factors, and current management strategies associated with mpox in Africa. This critical literature review was guided by Jesson & Laccy's guidelines on conducting critical literature reviews. We searched PubMed and Google Scholar databases and websites of the World Health Organization and health ministries in different African countries. We included articles written in English and published between 2010 and 2023. The synthesis of findings involved several steps, including summarizing themes, integrating themes, and linking themes to research questions. A total of 25 articles were included in this review. The review revealed that mpox cases are concentrated in Central African countries. The risk factors for mpox identified include being in contact with bushmeat or rodents, not having been vaccinated against smallpox, being HIV-positive, and having close physical contact with someone with the disease. The clinical presentation of mpox revealed in this review includes a skin rash, fever, lymphadenopathy, headache, pruritus, sore throat, and body aches. Four themes arose on strategies to prevent and control mpox in Africa. The prevention and control of mpox in Africa require an improvement in community education, vaccination, disease surveillance, and infection control measures.

Identifiants

pubmed: 39157420
doi: 10.1016/j.ijregi.2024.100402
pii: S2772-7076(24)00073-0
pmc: PMC11326932
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100402

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Auteurs

Godfrey Musuka (G)

Innovative Public Health and Development Solutions, Harare, Zimbabwe.

Enos Moyo (E)

University of Zimbabwe, Harare, Zimbabwe.

Nigel Tungwarara (N)

University of Zimbabwe, Harare, Zimbabwe.

Malizgani Mhango (M)

University of Zimbabwe, Harare, Zimbabwe.

Gashema Pierre (G)

University of Rwanda, Kigali, Rwanda.

Eric Saramba (E)

University of Rwanda, Kigali, Rwanda.

Patrick Gad Iradukunda (PG)

University of Rwanda, Kigali, Rwanda.

Tafadzwa Dzinamarira (T)

ICAP at Columbia University, Harare, Zimbabwe.

Classifications MeSH